Publications
Publications|Meeting ConferencesTitle: Beyond Recycling Antibodies: Crovalimab’s Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment
Author: Zenjiro Sampei, et al.
Journal: International Journal of Molecular Sciences. 2024, vol. 25, Issue. 21, 11679.
Title: SAIL66, a next generation CLDN6-targeting T-cell engager, demonstrates potent antitumor efficacy through dual binding to CD3/CD137
Author: Takayuki Kamikawa, et al.
Journal: Journal for Immuno Therapy of Cancer; 2024, vol.12, e009563.
Title: Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer
Author: Hirofumi Mikami, et al.
Journal: Cancer Immunology Research; 2024, OF1–OF12.
Title: Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease
Author: Yuu Okura, et al.
Journal: Nature Communication, 2023, vol. 14, 8502.
Title: Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement
Author: Zenjiro Sampei, et al.
Journal: Antibodies, 2023, vol. 12, no. 36.
Title: Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
Author: Taichi Kuramochi, et al.
Journal: mABs, 2022, vol 14, Issue 1, Pg. No: TBD
Title: Novel myostatin-specific antibody enhances muscle strength in muscle disease models
Author: Hiroyasu Muramatsu, et al.
Journal: Scientific Reports, 2021, vol. 11, 2160.
Title: Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineering
Author: Kenta Haraya, et al.
Journal: Drug Metabolism and Pharmacokinetics, 2019, vol. 34 no. 1, p. 25-41.
Title: Humanization and Simultaneous Optimization of Monoclonal Antibody
Author: Taichi Kuramochi, et al.
Journal: Methods in Molecular Biology, 2019, vol. 1904, p. 213-230.
Title: Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency
Author: Chen Chen, et al.
Journal: mAbs, 2019, vol 11, p632-638.
Title: Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody
Author: Zenjiro Sampei, et al.
Journal: PLoS ONE, 2018, vol. 13, no. 12, e0209509.
Title: 生命機能に迫る分子化学 生命分子を真似る，飾る，超える (CSJ: 30)
Author: Tomoyuki Igawa,et al.
Publication: 化学同人, 2018, p. 204.
Title: 次世代抗体医薬の衝撃
Author: Tomoyuki Igawa, et al.
Journal: 実験医学, 2018, vol. 36, no. 11, p. 1820-1829.
Title: Long-lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases
Author: Taku Fukuzawa, et al.
Journal: Scientific Reports, 2017, vol. 7, no. 1080.
Title: Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
Author: Tomoyuki Igawa, et al.
Journal: Immunological reviews, 2016, vol. 270, no. 1, p. 132-151.
